Accessibility Information

Users of assistive technologies such as screen readers should use the following link to activate Accessibility Mode before continuing: Learn more and Activate accessibility mode.

Broad Agency Announcement, Science and Technology Platforms Applied to Medical Countermeasure Development (Innovations) for BARDA

Solicitation Number: BAA-13-100-SOL-00014
Agency: Department of Health and Human Services
Office: Office of the Secretary
Location: Acquisitions Management, Contracts, & Grants (AMCG)
  • Print

Note:

There have been modifications to this notice. To view the most recent modification/amendment, click here
:
BAA-13-100-SOL-00014
:
Solicitation
:
Added: Jul 16, 2013 11:57 am Modified: Aug 16, 2013 1:54 pmTrack Changes
BARDA encourages the advanced research, development and acquisition of medical countermeasures such as vaccines, therapeutics, and diagnostics, as well as innovative approaches to support the preparedness mission and priorities of the HHS Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) articulated in the 2012 PHEMCE Implementation Plan. The Implementation Plan is located on the ASPR website: https://www.medicalcountermeasures.gov/media/13962/2012-phemce-implementation-plan.pdf

The Pandemic and All Hazard Preparedness Act Pub. L. No. 109-417, 42 U.S.C. § 241 et seq. (PAHPA; http://www.gpo.gov/fdsys/pkg/PLAW-109publ417/pdf/PLAW-109publ417.pdf) and The Pandemic and All Hazard Preparedness Reauthorization Act Pub. L. No. 113-5, (PAHPRA: http://www.gpo.gov/fdsys/pkg/PLAW-113publ5/pdf/PLAW-113publ5.pdf) authorizes BARDA to (i) conduct ongoing searches for, and support calls for, potential qualified countermeasures and qualified pandemic or epidemic products; (ii) direct and coordinate the countermeasure and product advanced research and development activities of the Department of Health and Human Services; (iii) establish strategic initiatives to accelerate countermeasure and product advanced research and development (which may include advanced research and development for purposes of fulfilling requirements under the Federal Food, Drug, and Cosmetic Act or section 351 of this Act) and innovation in such areas as the Secretary may identify as priority unmet need areas; and (iv) award contracts, grants, cooperative agreements, and enter into other transactions, for countermeasure and product advanced research and development.

A key to success in this broad, challenging mission is identifying and advancing innovative technologies that will provide capabilities for novel countermeasures with improved performance, as well as for their expedited development, manufacturing, and use. Through its Innovative Technologies program, BARDA has invested in basic and applied technology platforms that have enabled the development of new medical countermeasures and provided tools with the potential to be applied to other existing or future pathogens and threats.

The purpose of this announcement is to identify an Area of Interest (AOI) in which BARDA is currently seeking products, technologies, or capabilities that will advance effective medical countermeasure emergency response. BARDA is specifically interested in supporting the advancement of tools that can demonstrate an impact on the design, development, or use of a medical countermeasure for use in a public health emergency, but additional information that indicates the potential to be applied more broadly is welcomed. Technology platforms within this Strategic Science and Technology (SST) AOI may be applicable to vaccines, therapeutics, or diagnostics across the PHEMCE threat space.


SST Area of Interest #1: Technologies that facilitate administration of medical countermeasures during a public health emergency


1.1 Technologies, such as jet injectors or autoinjectors, that may allow vaccines or drugs to be delivered by parenteral administration with limited access to trained medical personnel resources


1.2 Technologies, such as oral or transdermal delivery, that allow non-parenteral administration by the user and may deliver the countermeasure over a longer time interval


The Government intends to conduct a full and open competition for this requirement in the form of a BAA. This synopsis is not a BAA; a BAA itself is anticipated to be posted on or about July 31, 2013. The Government expects to make 1 or more awards, subject to the availability of funds. The open period of the BAA will be specified in the BAA itself.


Comments to this announcement, referencing synopsis BAA-13-100-SOL-00014 may be submitted to the following email address: SST-BAA@hhs.gov

Please consult the list of document viewers if you cannot open a file.

Solicitation 1

Type:
Solicitation
Posted Date:
July 31, 2013
Description: Broad Agency Announcement - Science and Technology Platforms Applied to Medical Countermeasure Development (Innovations)

Pre-Proposal Conference - September 4, 2013

Type:
Other (Draft RFPs/RFIs, Responses to Questions, etc..)
Label:
Pre-Proposal Conference - September 4, 2013
Posted Date:
August 16, 2013
Description: Information about the 2013 BARDA Multi-Broad Agency Announcement Pre-Proposal Conference.

Pre-Proposal Conference Slides

Type:
Other (Draft RFPs/RFIs, Responses to Questions, etc..)
Label:
Pre-Proposal Conference Slides
Posted Date:
September 30, 2013
Description: Slides from the BARDA multi BAA Pre-Proposal Conference (September 4, 2013)

Amendment 1

Type:
Mod/Amendment
Posted Date:
October 17, 2013
Description: The purpose of this Amendment 1 to SST-BAA-13-100-SOL-00014 is to change the first interim White Paper submission deadline from October 30, 2013 to November 15, 2013. See Part 1, Section 2 and Part IV, Section 1 of SST-BAA-13-100-SOL-00014.
:
Office of the Assistant Secretary for Preparedness & Response (ASPR)
Department of Health and Human Services
330 Independence Ave. SW
G640
Washington, District of Columbia 20201
United States
:
Elizabeth Steiner ,
Contracting Officer
Phone: 202-205-8926
:
Nathaniel Cohen,
Contract Specialist
Phone: 202-205-8968